"This clinical adventure started over 10 years ago when we convinced Ron Moss then at NexBio to let us try #DAS181 as an #EIND in a couple of #BMT patients with progressive #Parainfluenza 3 Infection during the swine flu pandemic. free paper: https://t.co/rXF867iy3F"